If you made any changes in Pure these will be visible here soon.

Personal profile

Clinical activities

Grigoriadis as the head of the myeloma service at Monash Health has been given the responsibility to expand the program and increase the profile as a clinical trials site. Prior to his commencement in that role in 2013 there were no myeloma studies at Monash Health; Grigoriadis has actively engaged with industry and been a PI on a total of 7 studies. Grigoriadis is currently a PI on 2 open Phase III myeloma studies including lenalidomide +/- pembrolizumab and pomalidomide +/- pembrolizumab in relapsed / refractory patients.

Community service

1. Leukaemia Foundation Patient Conference, Multiple Myeloma (2012, 2014, 2015)

2. Cancer Drugs Access Committee (2016-)

Research interests



Myeloid malignancies

Lymphoid malignancies




Supervision interests

Myeloma, MDS

Monash teaching commitment





Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research area keywords

  • Haematology
  • Myeloma
  • MDS
  • Immunology
  • NF-kappaB
  • Iron


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or